IL326436A - Transgenic cells expressing trimeric complexes - Google Patents

Transgenic cells expressing trimeric complexes

Info

Publication number
IL326436A
IL326436A IL326436A IL32643626A IL326436A IL 326436 A IL326436 A IL 326436A IL 326436 A IL326436 A IL 326436A IL 32643626 A IL32643626 A IL 32643626A IL 326436 A IL326436 A IL 326436A
Authority
IL
Israel
Prior art keywords
cells expressing
engineered cells
trimeric complexes
expressing trimeric
complexes
Prior art date
Application number
IL326436A
Other languages
English (en)
Hebrew (he)
Inventor
Zhu Yingjie
Gu Haihua
Guo Jun
Cordoba Shaun
Original Assignee
Jw Therapeutics R & D Shanghai Co Ltd
Jw Therapeutics Shanghai Co Ltd
Zhu Yingjie
Gu Haihua
Guo Jun
Cordoba Shaun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jw Therapeutics R & D Shanghai Co Ltd, Jw Therapeutics Shanghai Co Ltd, Zhu Yingjie, Gu Haihua, Guo Jun, Cordoba Shaun filed Critical Jw Therapeutics R & D Shanghai Co Ltd
Publication of IL326436A publication Critical patent/IL326436A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4238—Regulators of development
    • A61K40/424—Apoptosis related proteins, e.g. survivin or livin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70507—CD2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/10—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the structure of the chimeric antigen receptor [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/10—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the structure of the chimeric antigen receptor [CAR]
    • A61K2239/11—Antigen recognition domain
    • A61K2239/15—Non-antibody based
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
IL326436A 2023-08-09 2024-08-08 Transgenic cells expressing trimeric complexes IL326436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2023112027 2023-08-09
PCT/CN2024/110621 WO2025031441A1 (fr) 2023-08-09 2024-08-08 Cellules modifiées exprimant des complexes trimères

Publications (1)

Publication Number Publication Date
IL326436A true IL326436A (en) 2026-04-01

Family

ID=94533569

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326436A IL326436A (en) 2023-08-09 2024-08-08 Transgenic cells expressing trimeric complexes

Country Status (4)

Country Link
KR (1) KR20260051076A (fr)
AU (1) AU2024323170A1 (fr)
IL (1) IL326436A (fr)
WO (1) WO2025031441A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025237409A1 (fr) * 2024-05-17 2025-11-20 Jw Therapeutics R & D (Shanghai) Co., Ltd. Polypeptide pour le traitement de maladies associées à gd2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230167769A (ko) * 2016-08-26 2023-12-11 베이롤 칼리지 오브 메드신 세포 치료요법을 위한 항상성 활성 사이토킨 수용체
CN118420783A (zh) * 2017-12-06 2024-08-02 恺兴生命科技(上海)有限公司 嵌合蛋白、表达嵌合蛋白的免疫效应细胞及其应用
US20220372105A1 (en) * 2019-09-05 2022-11-24 Poseida Therapeutics, Inc. Allogeneic cell compositions and methods of use
WO2021244486A1 (fr) * 2020-06-01 2021-12-09 上海君赛生物科技有限公司 Récepteur de conversion de signal et son utilisation
WO2022087453A1 (fr) * 2020-10-22 2022-04-28 Lyell Immunopharma, Inc. Récepteurs d'activation chimériques
EP4251645A1 (fr) * 2020-11-25 2023-10-04 Catamaran Bio, Inc. Agents thérapeutiques cellulaires modifiés par des modulateurs de signal et leurs méthodes d'utilisation
EP4453021A4 (fr) * 2021-12-22 2025-12-31 Memorial Sloan Kettering Cancer Center Cellules exprimant des polypeptides de ligand fas et inactivation de fas et leurs utilisations
EP4452298A4 (fr) * 2021-12-22 2025-11-19 Memorial Sloan Kettering Cancer Center Cellules exprimant un ligand fas et des polypeptides cflip et leurs utilisations

Also Published As

Publication number Publication date
WO2025031441A1 (fr) 2025-02-13
AU2024323170A1 (en) 2026-02-26
KR20260051076A (ko) 2026-04-15

Similar Documents

Publication Publication Date Title
IL326436A (en) Transgenic cells expressing trimeric complexes
GB2601481B (en) Electrochemical cell
EP4285427A4 (fr) Couches d'interconnexion dans des cellules électrochimiques
GB202005216D0 (en) Cell
GB202208605D0 (en) Engineered immune cells
IL317790A (en) Engineered T cells
ES3063339T3 (en) Briquette
CA3300918A1 (fr) Cellules modifiées exprimant des complexes trimères
IL320363A (en) Genetically modified cells
GB2606515B (en) Electrolyte compositions
GB202002538D0 (en) Isostatic pressing
IL311786A (en) hypoimmune cells
GB202303318D0 (en) Electrolyte regeneration
GB202205572D0 (en) Engineered T cells
GB202203111D0 (en) Electrolyte regeneration
GB202215416D0 (en) Battery materials
GB2609475B (en) Electrolyte compositions
GB202102637D0 (en) Engineered regulatory t cell
HK40102223A (en) Engineered t cells
GB202002620D0 (en) Engineered regulatory T cell
CA3279295A1 (fr) Lymphocytes t modifiés
CA3308202A1 (fr) Cellules modifiées
GB2626693B (en) Circuitry for electrochemical cells
GB202503038D0 (en) Engineered cell therapies
GB202500288D0 (en) Engineered cell therapies